Drug Trial Radar · NCT01021215
Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
Last checked: Nov 20, 2026Latest source record: Apr 2, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
May 2010
Primary completion
Aug 2012
Study completion Mar 2013
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Nov 26, 2009
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical research study is to learn how zileuton alone or the combination of zileuton and celecoxib may affect certain chemicals in the body that may be linked with a risk for smoking-related lung disease. These effects will be measured by a urine test
Conditions
- Tobacco Use Disorder
Interventions
ZileutonDrug
1200 mg twice daily given orally (PO) for 6 days
CelecoxibDrug
200 mg twice daily given orally for 6 days
laboratory biomarker analysisOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Urinary PGE-M Levels (Pre and Post Treatment)Time frame: Baseline and Day 6
- Median Urinary LTE4 Levels (Pre and Post Treatment)Time frame: Baseline and day 6
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Weill Cornell Medical College in New York City, Cornell University
New York, New York
MD Anderson Cancer Center - Consortium Lead Organzation
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.